4:持股变动声明-董事 Aryeh Jason
05/02 18:10 (美东)
4:持股变动声明-董事 KOZARICH JOHN W
04/26 18:39 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Davis Todd C
03/27 17:50 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-董事 Sabba Stephen L
03/07 13:30 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-董事 Aryeh Jason
03/06 17:31 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Reardon Andrew
02/29 18:54 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Korenberg Matthew E
02/29 18:54 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Espinoza Octavio
02/29 18:54 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Davis Todd C
02/29 18:54 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Reardon Andrew
02/16 20:12 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Korenberg Matthew E
02/16 20:12 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Espinoza Octavio
02/16 20:12 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Davis Todd C
02/16 20:12 (美东)
Ligand Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Macquarie Group Limited(5.66%),Macquarie Management Holdings Inc(5.66%)等
02/14 06:31 (美东)
Ligand Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(10.76%)
02/13 17:50 (美东)
Ligand Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(7.7%),Janus Henderson Triton Fund(5.1%)
02/13 15:41 (美东)
Ligand Pharmaceuticals | SC 13G:超过5%持股股东披露文件-THE GOLDMAN SACHS GROUP, INC.(6.8 %),GOLDMAN SACHS & CO. LLC(6.8 %)
02/12 19:45 (美东)
Ligand Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(17.0%)
01/22 00:00 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-高管 Reardon Andrew
01/04 00:00 (美东)
Ligand Pharmaceuticals | 4:持股变动声明-首席财务官 Espinoza Octavio
2023/12/06 15:27 (美东)
暂无数据
暂无数据